SOLENO THERAPEUTICS INC— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2017 (Q4)
Revenue
$92M
Gross Profit
$91M
Operating Income
$40M
Net Income
$39M
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) |
|---|---|
| Revenue | $92M |
| COGS | $863K |
| Gross Profit | $91M |
| R&D | $10M |
| SG&A | $41M |
| D&A | $509K |
| Other OpEx | $0 |
| Operating Income | $40M |
| Interest Exp. | $1M |
| Other Non-Op | $0 |
| Pretax Income | $39M |
| Tax | $0 |
| Net Income | $39M |
QuarterCharts · SEC EDGAR data · SLNO · Comparing FY2025 (Q4) vs FY2017 (Q4)